Narrow search
Showing 1 - 10 of 150,959
Cover Image
TRIPS flexibilities and access to medicines : an evaluation of barriers to employing compulsory licenses for patented pharmaceuticals at the WTO
Wong, Anna S. Y.; Cole, Clarke B.; Kohler, Jillian Clare - 2022
Under Articles 31 and 31bis of the TRIPS Agreement, WTO members may validly sanction the use of a patented invention without the patent owner's authorization by issuing a compulsory license (CL). In the pharmaceuticals space, governments have historically employed compulsory licenses to compel...
Persistent link: https://www.econbiz.de/10013469578
Cover Image
Big pharma and monopoly capitalism: a long-term view
Dosi, Giovanni; Marengo, Luigi; Staccioli, Jacopo; … - 2021
Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...
Persistent link: https://www.econbiz.de/10012604733
Cover Image
Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment? A Cross-Country Analysis of Pharmaceutical Patent Protection, 1978-2002
Qian, Yi - 2014
This paper evaluates the effects of patent protection on pharmaceutical innovations for twenty-six countries that established pharmaceutical patent laws during 1978-2002. Controlling for country characteristics through matched sampling techniques to establish two proper comparison sets among...
Persistent link: https://www.econbiz.de/10012751759
Cover Image
Special Section 301: US interference with the design and implementation of national patent laws
Correa, Carlos M. - 2020
Persistent link: https://www.econbiz.de/10012433847
Cover Image
Non-violation and situation complaints under the TRIPS Agreement : implications for developing countries
Syam, Nirmalya - 2020
Persistent link: https://www.econbiz.de/10012433958
Cover Image
Designing pro-health competition policies in developing countries
Ido, Vitor Henrique Pinto - 2020
Persistent link: https://www.econbiz.de/10012433548
Cover Image
Towards more affordable medicine: A proposal to waive certain obligations from the Agreement on TRIPS
Dhar, Biswajit; Gopakumar, K. M. - 2020
Agreement on Trade Related Aspects of Intellectual Property (TRIPS) was adopted in 1995 as one of the agreements under the World …" (World Trade Organization 2001: paragraph 4). Subsequently, the adoption of the Doha Declaration provided clarity with regard … on TRIPS with an objective of enhancing world's chances for prevention, containment, and treatment of COVID-19. …
Persistent link: https://www.econbiz.de/10012316008
Cover Image
Compulsory licensing as a remedy against excessive pricing of life-saving medicines
Kianzad, Behrang - 2024
The COVID-19 crisis intensified decade-long debates on the interaction between intellectual property rights (IPRs), competition law and access to affordable life-saving treatments and vaccines. Compulsory licensing of patented medicines is a tried-and-tested method to expand access, particularly...
Persistent link: https://www.econbiz.de/10014541546
Cover Image
Japan's Emerging Role in the Global Pharmaceutical Intellectual Property Regime : A Tale of Two Trade Agreements
Townsend, Belinda; Gleeson, Deborah; Lopert, Ruth - 2018
This paper explores Japan’s role in reshaping the global pharmaceutical intellectual property regime by examining its position on the expansion of intellectual property rights (IPR) in negotiations for two regional trade agreements: the Trans Pacific Partnership Agreement (TPP) and the...
Persistent link: https://www.econbiz.de/10014116529